Clinical Trials Logo

Uncomplicated Acute Appendicitis clinical trials

View clinical trials related to Uncomplicated Acute Appendicitis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06210269 Not yet recruiting - Clinical trials for Uncomplicated Acute Appendicitis

Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis

APPAC IV
Start date: January 2024
Phase: N/A
Study type: Interventional

APPAC IV, a randomized double-blind multicenter clinical trial comparing once daily oral moxifloxacin with placebo in an outpatient setting aims to evaluate whether antibiotics and hospitalization or both can be omitted in the treatment of uncomplicated appendicitis further significantly increasing cost savings and patient satisfaction. This is a direct research continuum to the previous trial triad: APPAC, APPAC II and APPAC III, which have already established that the majority of patients with uncomplicated acute appendicitis can be safely treated without surgery. The APPAC IV trial is based on a novel concept and approach to further optimize the nonoperative treatment of uncomplicated acute appendicitis with a high potential in resulting in major health care cost savings and potentially also in significant reduction of antibiotic use in an extremely common surgical emergency.